REVIEW
Accepted on 03 Feb 2025
A narrative review on diagnosis and treatment of ifosfamide-induced encephalopathy, the perspective of a EURACAN reference center for sarcomas
doi 10.3389/fphar.2025.1512966
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Pharmacotherapeutics for Bone and Soft Tissue Tumours
Pharmacotherapeutics for Bone and Soft Tissue Tumours
5,532
Total downloads
19k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 13 Dec 2024
Immunotherapy for lung adenocarcinoma patients with bone metastases: who really needs it
doi 10.3389/fimmu.2024.1457916
- 402 views
ORIGINAL RESEARCH
Published on 20 Aug 2024
Radiological evaluation of response in patients with locally advanced/metastatic soft tissue sarcoma treated with trabectedin
doi 10.3389/fphar.2024.1411707
- 486 views
ORIGINAL RESEARCH
Published on 07 Mar 2024
Surgery combined with anlotinib for local control of patients with resectable extremity desmoid fibromatosis: a retrospective study
doi 10.3389/fphar.2024.1357071
- 424 views
CLINICAL TRIAL
Published on 01 Feb 2024
Combining nanoparticle albumin-bound paclitaxel with camrelizumab in advanced soft tissue sarcoma: activity, safety, and future perspectives
doi 10.3389/fphar.2024.1335054
- 1,441 views
- 1 citation
ORIGINAL RESEARCH
Published on 13 Nov 2023
Apatinib plus chemotherapy for non-metastatic osteosarcoma: a retrospective cohort study
doi 10.3389/fonc.2023.1227461
- 762 views
CASE REPORT
Published on 09 Nov 2023
Case report: the dissociated response and clinical benefit of primary leiomyosarcoma of the bone treated with penpulimab plus lenvatinib after failed multi-line therapy
doi 10.3389/fphar.2023.1239699
- 1,018 views
ORIGINAL RESEARCH
Published on 05 Sep 2023
Argon-helium knife cryoablation plus programmed cell death protein 1 inhibitor in the treatment of advanced soft tissue sarcomas: there is no evidence of the synergistic effects of this combination therapy
doi 10.3389/fonc.2023.1185291
- 933 views
- 1 citation
ORIGINAL RESEARCH
Published on 16 Aug 2023
m7G-related genes predict prognosis and affect the immune microenvironment and drug sensitivity in osteosarcoma
doi 10.3389/fphar.2023.1158775
- 1,384 views
- 1 citation
REVIEW
Published on 11 Aug 2023
Chemotherapeutic drugs for soft tissue sarcomas: a review
doi 10.3389/fphar.2023.1199292
- 5,062 views
- 16 citations
ORIGINAL RESEARCH
Published on 11 Aug 2023
Oral fibroblasts rescue osteogenic differentiation of mesenchymal stem cells after exposure to Zoledronic acid in a paracrine effect
doi 10.3389/fphar.2023.1172705
- 1,173 views
- 1 citation
CASE REPORT
Published on 31 May 2023
Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule
doi 10.3389/fonc.2023.1190123
- 1,425 views
- 1 citation
Published in
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Translational Pharmacology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted:
Impact
- 19kTopic views
- 12kArticle views
- 5,532Article downloads